| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 66 | 2021 | 520 | 11.340 |
Why?
|
| Aging | 43 | 2021 | 942 | 6.400 |
Why?
|
| Muscle Fibers, Skeletal | 29 | 2020 | 108 | 5.270 |
Why?
|
| Calcium | 34 | 2015 | 339 | 4.090 |
Why?
|
| Calcium Channels, L-Type | 32 | 2016 | 46 | 3.810 |
Why?
|
| Pericytes | 10 | 2017 | 32 | 3.620 |
Why?
|
| Muscle Contraction | 27 | 2019 | 175 | 3.420 |
Why?
|
| Insulin-Like Growth Factor I | 20 | 2011 | 85 | 3.150 |
Why?
|
| Calcium Channels | 23 | 2019 | 63 | 2.890 |
Why?
|
| Mice | 56 | 2019 | 2571 | 2.380 |
Why?
|
| Animals | 94 | 2020 | 8199 | 2.240 |
Why?
|
| Troponin T | 7 | 2018 | 91 | 2.230 |
Why?
|
| Motor Neurons | 11 | 2020 | 50 | 1.980 |
Why?
|
| Sarcoplasmic Reticulum | 15 | 2015 | 17 | 1.960 |
Why?
|
| Muscle Strength | 11 | 2019 | 135 | 1.830 |
Why?
|
| Muscle Fibers, Fast-Twitch | 10 | 2017 | 26 | 1.530 |
Why?
|
| Resistance Training | 4 | 2019 | 58 | 1.530 |
Why?
|
| Neuromuscular Junction | 10 | 2021 | 70 | 1.460 |
Why?
|
| Calcium Signaling | 7 | 2013 | 49 | 1.320 |
Why?
|
| Muscle Fibers, Slow-Twitch | 8 | 2016 | 17 | 1.300 |
Why?
|
| Mice, Inbred C57BL | 18 | 2020 | 792 | 1.240 |
Why?
|
| Synaptic Potentials | 2 | 2020 | 5 | 1.240 |
Why?
|
| Cell Nucleus | 5 | 2018 | 111 | 1.200 |
Why?
|
| Muscle Proteins | 11 | 2015 | 63 | 1.100 |
Why?
|
| Gene Expression Regulation | 13 | 2018 | 478 | 1.010 |
Why?
|
| Calpain | 2 | 2017 | 14 | 1.000 |
Why?
|
| Myosin Heavy Chains | 6 | 2020 | 84 | 0.990 |
Why?
|
| Obesity | 4 | 2019 | 1111 | 0.980 |
Why?
|
| Caloric Restriction | 3 | 2019 | 92 | 0.980 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 14 | 2015 | 21 | 0.940 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 257 | 0.940 |
Why?
|
| Muscle Cells | 2 | 2018 | 7 | 0.940 |
Why?
|
| Excitation Contraction Coupling | 4 | 2015 | 8 | 0.930 |
Why?
|
| Transcription, Genetic | 6 | 2018 | 140 | 0.880 |
Why?
|
| Membrane Proteins | 6 | 2013 | 243 | 0.870 |
Why?
|
| Regeneration | 3 | 2015 | 178 | 0.850 |
Why?
|
| Muscular Atrophy | 10 | 2018 | 74 | 0.840 |
Why?
|
| Sarcopenia | 3 | 2021 | 50 | 0.820 |
Why?
|
| Green Fluorescent Proteins | 6 | 2014 | 70 | 0.800 |
Why?
|
| Synaptic Vesicles | 2 | 2020 | 7 | 0.790 |
Why?
|
| Muscle Development | 4 | 2015 | 52 | 0.750 |
Why?
|
| Sympathetic Nervous System | 2 | 2021 | 34 | 0.730 |
Why?
|
| Physical Conditioning, Animal | 4 | 2017 | 35 | 0.710 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 68 | 0.710 |
Why?
|
| Antigens | 5 | 2016 | 34 | 0.700 |
Why?
|
| Proteoglycans | 5 | 2016 | 34 | 0.700 |
Why?
|
| Muscles | 10 | 1993 | 69 | 0.700 |
Why?
|
| Muscle Fatigue | 4 | 2016 | 13 | 0.680 |
Why?
|
| Cells, Cultured | 11 | 2014 | 839 | 0.650 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2020 | 8 | 0.650 |
Why?
|
| RNA, Messenger | 6 | 2013 | 499 | 0.640 |
Why?
|
| Ion Channel Gating | 7 | 2010 | 20 | 0.640 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2020 | 35 | 0.640 |
Why?
|
| Cell Line | 9 | 2018 | 454 | 0.630 |
Why?
|
| Acute Lung Injury | 3 | 2015 | 36 | 0.620 |
Why?
|
| Sulfonamides | 2 | 2017 | 86 | 0.620 |
Why?
|
| Receptors, Cholinergic | 2 | 2018 | 26 | 0.620 |
Why?
|
| Amyotrophic Lateral Sclerosis | 8 | 2007 | 61 | 0.610 |
Why?
|
| Acetylcholine | 2 | 2018 | 69 | 0.590 |
Why?
|
| Clenbuterol | 1 | 2019 | 2 | 0.590 |
Why?
|
| Sympathomimetics | 1 | 2019 | 5 | 0.590 |
Why?
|
| Albuterol | 1 | 2019 | 17 | 0.590 |
Why?
|
| Humans | 42 | 2021 | 32274 | 0.580 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2015 | 7 | 0.580 |
Why?
|
| TRPV Cation Channels | 1 | 2019 | 26 | 0.580 |
Why?
|
| Rats | 29 | 2004 | 1895 | 0.570 |
Why?
|
| Ribonucleotide Reductases | 1 | 2018 | 6 | 0.560 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 52 | 0.540 |
Why?
|
| Patch-Clamp Techniques | 11 | 2012 | 76 | 0.540 |
Why?
|
| Neovascularization, Physiologic | 3 | 2016 | 114 | 0.530 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.530 |
Why?
|
| Intermediate Filament Proteins | 3 | 2012 | 11 | 0.530 |
Why?
|
| Lipolysis | 1 | 2017 | 13 | 0.530 |
Why?
|
| Aged | 15 | 2020 | 10260 | 0.510 |
Why?
|
| Central Nervous System | 2 | 2007 | 47 | 0.500 |
Why?
|
| Cell Differentiation | 7 | 2017 | 461 | 0.500 |
Why?
|
| Adipogenesis | 2 | 2015 | 30 | 0.500 |
Why?
|
| Membrane Potentials | 17 | 2013 | 76 | 0.500 |
Why?
|
| DNA | 1 | 2018 | 223 | 0.500 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 124 | 0.490 |
Why?
|
| Male | 24 | 2019 | 19437 | 0.490 |
Why?
|
| Glioblastoma | 2 | 2016 | 159 | 0.480 |
Why?
|
| Isometric Contraction | 5 | 2016 | 28 | 0.480 |
Why?
|
| Cell Lineage | 5 | 2017 | 65 | 0.480 |
Why?
|
| Wasting Syndrome | 2 | 2015 | 14 | 0.470 |
Why?
|
| Muscle Denervation | 8 | 2017 | 29 | 0.470 |
Why?
|
| Female | 20 | 2019 | 19942 | 0.460 |
Why?
|
| Weight Loss | 2 | 2017 | 410 | 0.450 |
Why?
|
| Quadriceps Muscle | 2 | 2012 | 29 | 0.430 |
Why?
|
| Myogenin | 1 | 2014 | 5 | 0.430 |
Why?
|
| Cicatrix | 1 | 2014 | 39 | 0.430 |
Why?
|
| Troponin | 1 | 2015 | 101 | 0.420 |
Why?
|
| Neutrophils | 1 | 2015 | 120 | 0.420 |
Why?
|
| Lipids | 1 | 2015 | 253 | 0.420 |
Why?
|
| Myoblasts | 1 | 2014 | 41 | 0.410 |
Why?
|
| Apoptosis | 2 | 2013 | 375 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 75 | 0.410 |
Why?
|
| Knee Joint | 1 | 2015 | 128 | 0.400 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 53 | 0.400 |
Why?
|
| Wound Healing | 1 | 2015 | 185 | 0.400 |
Why?
|
| Ischemia | 1 | 2014 | 115 | 0.390 |
Why?
|
| Exercise Therapy | 1 | 2015 | 250 | 0.380 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 119 | 0.380 |
Why?
|
| MicroRNAs | 1 | 2015 | 181 | 0.370 |
Why?
|
| Neuroglia | 1 | 2012 | 30 | 0.370 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 637 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 5 | 2016 | 203 | 0.350 |
Why?
|
| Eating | 1 | 2012 | 77 | 0.350 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 3898 | 0.340 |
Why?
|
| Electrophysiology | 9 | 2007 | 76 | 0.340 |
Why?
|
| Transgenes | 1 | 2011 | 46 | 0.330 |
Why?
|
| Muscle Weakness | 2 | 2009 | 34 | 0.330 |
Why?
|
| Hindlimb | 5 | 2014 | 53 | 0.320 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 24 | 0.310 |
Why?
|
| Mice, Inbred DBA | 6 | 2008 | 42 | 0.310 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2015 | 38 | 0.300 |
Why?
|
| Luminescent Proteins | 3 | 2014 | 25 | 0.300 |
Why?
|
| Receptors, Nicotinic | 4 | 1998 | 61 | 0.300 |
Why?
|
| Spinal Cord | 4 | 2007 | 137 | 0.290 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2004 | 17 | 0.290 |
Why?
|
| Age Factors | 6 | 2017 | 1179 | 0.280 |
Why?
|
| Energy Intake | 2 | 1998 | 122 | 0.270 |
Why?
|
| Time Factors | 7 | 2015 | 2204 | 0.270 |
Why?
|
| Receptor, IGF Type 1 | 2 | 1997 | 9 | 0.270 |
Why?
|
| Diaphragm | 4 | 1993 | 37 | 0.260 |
Why?
|
| Flow Cytometry | 3 | 2013 | 183 | 0.260 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 41 | 0.260 |
Why?
|
| Gene Expression | 4 | 2013 | 345 | 0.260 |
Why?
|
| Immunoglobulin G | 6 | 1994 | 129 | 0.250 |
Why?
|
| Aminophylline | 3 | 1993 | 8 | 0.250 |
Why?
|
| Protein Binding | 2 | 2018 | 244 | 0.250 |
Why?
|
| Mice, Knockout | 6 | 2015 | 454 | 0.230 |
Why?
|
| Body Composition | 3 | 2015 | 327 | 0.220 |
Why?
|
| Mice, Nude | 3 | 2016 | 285 | 0.220 |
Why?
|
| Exercise | 3 | 2019 | 603 | 0.220 |
Why?
|
| Mutation | 1 | 2007 | 497 | 0.220 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2005 | 51 | 0.220 |
Why?
|
| Electric Conductivity | 3 | 1999 | 10 | 0.220 |
Why?
|
| Motor Activity | 3 | 2015 | 332 | 0.210 |
Why?
|
| Calcineurin | 1 | 2004 | 3 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 6 | 0.210 |
Why?
|
| Electric Stimulation | 3 | 2020 | 135 | 0.210 |
Why?
|
| Fibrosis | 2 | 2015 | 126 | 0.200 |
Why?
|
| Motor Cortex | 1 | 2003 | 13 | 0.200 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 9 | 0.200 |
Why?
|
| Nifedipine | 6 | 1993 | 10 | 0.190 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 221 | 0.190 |
Why?
|
| Biopsy, Needle | 2 | 2020 | 94 | 0.190 |
Why?
|
| Rats, Inbred F344 | 5 | 2003 | 151 | 0.180 |
Why?
|
| Action Potentials | 9 | 2017 | 212 | 0.180 |
Why?
|
| Actins | 2 | 2014 | 54 | 0.180 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 55 | 0.170 |
Why?
|
| Electroporation | 2 | 2011 | 15 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1083 | 0.170 |
Why?
|
| Verapamil | 2 | 1993 | 8 | 0.160 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 124 | 0.160 |
Why?
|
| Locus Coeruleus | 1 | 2020 | 23 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2015 | 727 | 0.160 |
Why?
|
| Cell Survival | 3 | 2007 | 288 | 0.150 |
Why?
|
| Rats, Wistar | 6 | 1996 | 111 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2017 | 131 | 0.150 |
Why?
|
| Genes, Reporter | 2 | 2013 | 41 | 0.150 |
Why?
|
| Luciferases | 3 | 2004 | 33 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 63 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 186 | 0.140 |
Why?
|
| Protein Subunits | 2 | 2009 | 40 | 0.140 |
Why?
|
| Consensus Sequence | 1 | 2018 | 11 | 0.140 |
Why?
|
| Models, Biological | 2 | 2017 | 408 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 120 | 0.140 |
Why?
|
| Rats, Inbred Strains | 8 | 1991 | 76 | 0.140 |
Why?
|
| Coculture Techniques | 2 | 2016 | 78 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 121 | 0.130 |
Why?
|
| Caffeine | 6 | 2003 | 28 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2012 | 60 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 29 | 0.130 |
Why?
|
| Middle Aged | 7 | 2018 | 11848 | 0.130 |
Why?
|
| Adult | 6 | 2018 | 9256 | 0.130 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 23 | 0.120 |
Why?
|
| Tetanus Toxin | 2 | 2006 | 5 | 0.120 |
Why?
|
| Neurons | 1 | 2020 | 486 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 19 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 27 | 0.120 |
Why?
|
| Phenotype | 2 | 2016 | 621 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 79 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 7 | 0.120 |
Why?
|
| Torque | 1 | 2015 | 21 | 0.120 |
Why?
|
| Kinetics | 5 | 2011 | 250 | 0.110 |
Why?
|
| Tetraethylammonium Compounds | 3 | 1993 | 4 | 0.110 |
Why?
|
| Gene Library | 1 | 2015 | 7 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 10 | 0.110 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.110 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 23 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 34 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 19 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2015 | 17 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2015 | 32 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 69 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2015 | 50 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2014 | 80 | 0.110 |
Why?
|
| Stem Cells | 1 | 2017 | 321 | 0.110 |
Why?
|
| Nerve Growth Factors | 2 | 2005 | 14 | 0.110 |
Why?
|
| Chromatin | 1 | 2014 | 26 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2013 | 8 | 0.100 |
Why?
|
| Laryngeal Muscles | 1 | 2014 | 17 | 0.100 |
Why?
|
| Rats, Inbred BN | 3 | 1998 | 31 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 2 | 2011 | 24 | 0.100 |
Why?
|
| Collagen | 1 | 2014 | 229 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 3 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 4 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2006 | 414 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 252 | 0.100 |
Why?
|
| Leucine Zippers | 1 | 2013 | 3 | 0.100 |
Why?
|
| Nuclear Localization Signals | 1 | 2013 | 4 | 0.100 |
Why?
|
| Annexin A5 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 14 | 0.100 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1993 | 1 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 48 | 0.100 |
Why?
|
| Biopsy | 1 | 2013 | 252 | 0.100 |
Why?
|
| Malignant Hyperthermia | 1 | 2012 | 6 | 0.100 |
Why?
|
| Isotonic Contraction | 1 | 2012 | 7 | 0.090 |
Why?
|
| Myofibrils | 1 | 2012 | 7 | 0.090 |
Why?
|
| Cachexia | 1 | 2012 | 7 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2012 | 47 | 0.090 |
Why?
|
| Tetrodotoxin | 3 | 2005 | 14 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2012 | 124 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 246 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 26 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 98 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 42 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 98 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 54 | 0.090 |
Why?
|
| 4-Aminopyridine | 2 | 1991 | 6 | 0.090 |
Why?
|
| Leptin | 1 | 2012 | 61 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 4 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 93 | 0.090 |
Why?
|
| North Carolina | 1 | 2015 | 1300 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2013 | 193 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 15 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 62 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 506 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 425 | 0.090 |
Why?
|
| Proteomics | 1 | 2012 | 97 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 174 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 264 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 216 | 0.080 |
Why?
|
| Osmolar Concentration | 2 | 2003 | 23 | 0.080 |
Why?
|
| Cresols | 1 | 2010 | 5 | 0.080 |
Why?
|
| Body Weight | 1 | 2012 | 323 | 0.080 |
Why?
|
| Insulin | 1 | 2012 | 359 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 87 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3416 | 0.080 |
Why?
|
| Base Sequence | 2 | 2002 | 252 | 0.080 |
Why?
|
| Cytosol | 1 | 2009 | 23 | 0.080 |
Why?
|
| Isradipine | 2 | 1999 | 2 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 359 | 0.080 |
Why?
|
| Ruthenium | 1 | 1989 | 1 | 0.070 |
Why?
|
| Ruthenium Red | 1 | 1989 | 2 | 0.070 |
Why?
|
| Membranes | 1 | 2008 | 12 | 0.070 |
Why?
|
| Ions | 1 | 2008 | 15 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 543 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2240 | 0.070 |
Why?
|
| Capillaries | 1 | 2008 | 25 | 0.070 |
Why?
|
| Theophylline | 1 | 1988 | 4 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 1988 | 55 | 0.070 |
Why?
|
| Respiratory Muscles | 1 | 1987 | 5 | 0.070 |
Why?
|
| Aminopyridines | 1 | 1987 | 6 | 0.070 |
Why?
|
| Xanthenes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 96 | 0.070 |
Why?
|
| Calcium Channel Blockers | 3 | 1999 | 53 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2007 | 10 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 18 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 556 | 0.070 |
Why?
|
| Organ Size | 2 | 2007 | 221 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 1997 | 43 | 0.070 |
Why?
|
| Glycine | 1 | 2007 | 26 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 30 | 0.070 |
Why?
|
| Cell Size | 1 | 2007 | 40 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 52 | 0.060 |
Why?
|
| Nicotinic Agonists | 2 | 1998 | 39 | 0.060 |
Why?
|
| Longevity | 1 | 2007 | 23 | 0.060 |
Why?
|
| Dihydropyridines | 3 | 1997 | 3 | 0.060 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2006 | 6 | 0.060 |
Why?
|
| Phosphorylation | 2 | 1997 | 250 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 897 | 0.060 |
Why?
|
| Nicotine | 3 | 1998 | 164 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 72 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2007 | 139 | 0.060 |
Why?
|
| Thymidine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Ryanodine | 2 | 2015 | 4 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2005 | 16 | 0.060 |
Why?
|
| Potassium | 3 | 1990 | 40 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2005 | 85 | 0.050 |
Why?
|
| Fura-2 | 2 | 1995 | 4 | 0.050 |
Why?
|
| Transfection | 2 | 2002 | 204 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2006 | 109 | 0.050 |
Why?
|
| Efferent Pathways | 1 | 2003 | 10 | 0.050 |
Why?
|
| Electromyography | 1 | 2004 | 67 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 1984 | 46 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2003 | 19 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2003 | 18 | 0.050 |
Why?
|
| Extremities | 1 | 2003 | 54 | 0.050 |
Why?
|
| Cholinesterases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 74 | 0.050 |
Why?
|
| Apamin | 2 | 1993 | 2 | 0.050 |
Why?
|
| Tetraethylammonium | 2 | 1993 | 3 | 0.050 |
Why?
|
| SOXD Transcription Factors | 1 | 2002 | 1 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 2 | 0.050 |
Why?
|
| GATA4 Transcription Factor | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 24 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 50 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 74 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 149 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 22 | 0.040 |
Why?
|
| DNA Probes | 1 | 2001 | 18 | 0.040 |
Why?
|
| Rabbits | 2 | 2006 | 219 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2000 | 3 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2002 | 183 | 0.040 |
Why?
|
| Aconitine | 2 | 1998 | 5 | 0.040 |
Why?
|
| Reaction Time | 1 | 2001 | 123 | 0.040 |
Why?
|
| Drinking Behavior | 1 | 2020 | 11 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 3 | 0.040 |
Why?
|
| Biophysics | 1 | 2000 | 13 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2000 | 10 | 0.040 |
Why?
|
| Algorithms | 1 | 2003 | 536 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 101 | 0.040 |
Why?
|
| Intracellular Space | 1 | 1999 | 17 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1999 | 32 | 0.040 |
Why?
|
| Foot | 1 | 1999 | 40 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 1999 | 3 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 1984 | 534 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 1999 | 136 | 0.040 |
Why?
|
| Food Deprivation | 1 | 1998 | 4 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2015 | 863 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 21 | 0.040 |
Why?
|
| Nicotinic Antagonists | 1 | 1998 | 17 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 55 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1997 | 3 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 2 | 0.030 |
Why?
|
| Genistein | 1 | 1997 | 17 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1998 | 471 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1997 | 71 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 95 | 0.030 |
Why?
|
| Isoflavones | 1 | 1997 | 103 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 114 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 89 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 167 | 0.030 |
Why?
|
| Biological Transport | 1 | 1995 | 75 | 0.030 |
Why?
|
| Ion Transport | 1 | 1995 | 6 | 0.030 |
Why?
|
| Glycogen Phosphorylase | 1 | 2015 | 1 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2015 | 17 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1995 | 13 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 717 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1994 | 46 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 729 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2014 | 10 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 1993 | 3 | 0.030 |
Why?
|
| Cerebellar Cortex | 1 | 1993 | 4 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1993 | 16 | 0.030 |
Why?
|
| Antibodies | 1 | 1994 | 56 | 0.030 |
Why?
|
| Sarcomeres | 1 | 1993 | 5 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1993 | 86 | 0.020 |
Why?
|
| Manganese | 1 | 2013 | 8 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 1993 | 38 | 0.020 |
Why?
|
| Diet | 1 | 2015 | 383 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1993 | 81 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 69 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 211 | 0.020 |
Why?
|
| RING Finger Domains | 1 | 2012 | 2 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 59 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cadmium | 1 | 1991 | 7 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 247 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 299 | 0.020 |
Why?
|
| Reference Values | 1 | 1991 | 238 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 651 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 1990 | 6 | 0.020 |
Why?
|
| Mammals | 1 | 1989 | 14 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1986 | 13 | 0.020 |
Why?
|
| Solutions | 1 | 1987 | 40 | 0.020 |
Why?
|
| Calsequestrin | 1 | 2006 | 2 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 112 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2006 | 45 | 0.010 |
Why?
|
| Polyamines | 2 | 1995 | 11 | 0.010 |
Why?
|
| Autoimmune Diseases | 2 | 1995 | 46 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 126 | 0.010 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 1998 | 1 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 1998 | 2 | 0.010 |
Why?
|
| Benzylidene Compounds | 1 | 1998 | 5 | 0.010 |
Why?
|
| Insecticides | 1 | 1998 | 15 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 22 | 0.010 |
Why?
|
| Ligands | 1 | 1998 | 90 | 0.010 |
Why?
|
| Pyridines | 1 | 1998 | 79 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 144 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 193 | 0.010 |
Why?
|
| Kidney | 1 | 1998 | 521 | 0.010 |
Why?
|
| Ionophores | 1 | 1994 | 3 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1993 | 5 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1993 | 16 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 150 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1993 | 15 | 0.010 |
Why?
|